Data Insights

Paclitaxel by Samyang Biopharmaceuticals for Laryngeal Cancer: Likelihood of Approval

Paclitaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase II for Laryngeal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Laryngeal Cancer

Data Insights

Paclitaxel by Samyang Biopharmaceuticals for Skin Cancer: Likelihood of Approval

Paclitaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase II for Skin Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Skin Cancer

Data Insights

Paclitaxel by Samyang Biopharmaceuticals for Oral Cancer: Likelihood of Approval

Paclitaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase II for Oral Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Oral Cancer

Data Insights

Paclitaxel by Samyang Biopharmaceuticals for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval

Paclitaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase II for Head And Neck Squamous Cell Carcinoma...

Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Head And Neck Squamous Cell Carcinoma (HNSC)

Data Insights

Paclitaxel by Samyang Biopharmaceuticals for Esophageal Cancer: Likelihood of Approval

Paclitaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase II for Esophageal Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Esophageal Cancer

Data Insights

Docetaxel by Samyang Biopharmaceuticals for Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer): Likelihood of Approval

Docetaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase III for Human Epidermal Growth Factor Receptor 2...

Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer)

Data Insights

Paclitaxel by Samyang Biopharmaceuticals for Cervical Cancer: Likelihood of Approval

Paclitaxel is under clinical development by Samyang Biopharmaceuticals and currently in Phase I for Cervical Cancer. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - Paclitaxel in Cervical Cancer